KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma

SIMPLE SUMMARY: Malignant pleural mesothelioma (MPM) is an aggressive tumor with implacable prognosis. It commonly harbors loss-of-function mutations in BAP1, NF2, CDKN2A and TP53, although their pathogenetic role is still uncertain since these genetic alterations, if isolated, do not cause MPM in m...

Descripción completa

Detalles Bibliográficos
Autores principales: Vannucchi, Margherita, Pennati, Veronica, Mencaroni, Clelia, Defraia, Chiara, Bardhi, Ledi, Castiglione, Francesca, Bellan, Cristiana, Comin, Camilla Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093256/
https://www.ncbi.nlm.nih.gov/pubmed/37046732
http://dx.doi.org/10.3390/cancers15072072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093256/
https://www.ncbi.nlm.nih.gov/pubmed/37046732
http://dx.doi.org/10.3390/cancers15072072

Ejemplares similares